Clinical Trial Update: Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating decolonization of carbapenem-resistant Enterobacterales (CRE) in asymptomatically colonized patients using neomycin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacterales Infection Colonization

Drugs mentioned

• Neomycin (neomycin)

Snippet

Sponsor: Mahidol University | Conditions: Colonization, Asymptomatic | Phase 4 | Status: UNKNOWN